Omnicell, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

26 Feb 2026

OMCL

10-K: Omnicell's 2025 Annual Report: Service Growth Amid Profitability Dip

Omnicell reports a 7% increase in total revenues for 2025, driven by service growth and strategic investments in autonomous medication management, despite a significant drop in net income and reduced product bookings.

NASDAQ

27 Feb 2025

OMCL

Omnicell, INC

10-K: Omnicell's 2024 10-K Filing: Navigating Market Challenges and Charting Future Growth

Omnicell's 2024 10-K filing reveals a company navigating market headwinds while strategically investing in long-term growth through automation and recurring revenue streams.

NASDAQ

28 Feb 2024

OMCL

Omnicell, INC

10-K: Omnicell, Inc. 2023 Annual Report: Subsidiary List and Business Overview

Omnicell's 2023 annual report provides a list of subsidiaries and details the company's focus on medication management solutions and the vision of the Autonomous Pharmacy.